Vaccine Technologies Global Market Report 2025

Description

Vaccine technologies encompass the scientific techniques and tools utilized to create, manufacture, and administer vaccines that activate the immune system to identify and combat pathogens such as viruses, bacteria, or other harmful microorganisms. The primary goal of these technologies is to safely trigger immunity, thereby preventing diseases and helping to control the spread of infections.

There are several key types of vaccine technologies, including recombinant, conjugate, subunit, inactivated, live attenuated, and toxoid vaccines. These vaccines work by using specific components of a virus or bacterium-such as proteins or sugars-instead of the entire pathogen to safely elicit an immune response. Vaccines are delivered through various routes like parenteral, oral, and nasal methods, and are used for both infectious and non-infectious disease applications. They are suitable for all age groups, from children to adults, and are distributed through multiple channels including hospitals, retail pharmacies, government programs, and other providers.

The vaccine technologies market research report is one of a series of new reports from The Business Research Company that provides vaccine technologies market statistics, including vaccine technologies industry global market size, regional shares, competitors with a vaccine technologies market share, detailed vaccine technologies market segments, market trends and opportunities, and any further data you may need to thrive in the vaccine technologies industry. This vaccine technologies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The vaccine technologies market size has grown rapidly in recent years. It will grow from $55.59 billion in 2024 to $61.38 billion in 2025 at a compound annual growth rate (CAGR) of 10.4%. Growth during the historical period was supported by increasing cases of infectious diseases, enhanced government funding for vaccine-related research, pandemic outbreaks, heightened public awareness of vaccines' advantages, and the broadening of immunization initiatives.

The vaccine technologies market size is expected to see rapid growth in the next few years. It will grow to $90.7 billion in 2029 at a compound annual growth rate (CAGR) of 10.1%. This future growth will be driven by the rising demand for mRNA-based vaccines, increased investments in personalized vaccine development, heightened emphasis on cancer immunization, a growing burden of chronic illnesses, and improved public understanding of vaccine safety. Key trends anticipated during the forecast period include the emergence of mRNA and DNA vaccine platforms, advancements in nanoparticle-based delivery methods, increased use of combination vaccines, the uptake of thermostable formulations, and innovations in needle-free delivery systems.

The growing prevalence of infectious diseases is anticipated to drive the expansion of the vaccine technologies market in the coming years. Infectious diseases are illnesses caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites that can be transmitted from one individual to another. The rise in these diseases is largely attributed to increased global travel, which accelerates the spread of pathogens across borders. Vaccine technologies help in combating infectious diseases by eliciting targeted immune responses that prevent and control infections. These technologies contribute to public health by reducing the spread and severity of diseases, thereby improving overall healthcare outcomes. For example, in February 2024, the UK Health Security Agency reported that tuberculosis cases in England rose to 4,850 in 2023, marking a 10.7% increase from 4,380 cases in 2022. This surge in infectious diseases is a key factor propelling the growth of the vaccine technologies market.

Leading companies in the vaccine technologies sector are prioritizing the development of advanced solutions such as quadrivalent influenza vaccines to enhance immunization coverage and reduce the risk of strain mismatch. These vaccines are designed to protect against four influenza virus strains-two influenza A and two influenza B-offering broader protection than traditional trivalent vaccines. For instance, in February 2025, Zydus Lifesciences, an India-based pharmaceutical firm, introduced VaxiFlu-4, a quadrivalent influenza vaccine. This vaccine provides seasonal protection against four strains of influenza, including both types A and B. It is administered as a single-dose intramuscular injection and is suitable for both adults and children, helping to lessen the impact of seasonal influenza by offering more comprehensive strain coverage.

In December 2023, AstraZeneca plc, a UK-based biopharmaceutical company, acquired Icosavax Inc. for $1.1 billion. This acquisition was aimed at strengthening AstraZeneca's respiratory vaccine portfolio through the addition of Icosavax's innovative protein virus-like particle (VLP) platform. This platform includes a phase III-ready combination vaccine candidate, IVX-A12, which targets both respiratory syncytial virus (RSV) and human metapneumovirus (hMPV). Icosavax is a US-based biotechnology company that focuses on the development of VLP-based vaccines for respiratory illnesses.

Major players in the vaccine technologies market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc, Sanofi S.A., AstraZeneca plc, Novartis AG, GSK plc, Moderna Inc., CSL Limited, Bharat Biotech International Limited, Bavarian Nordic A/S, Takeda Pharmaceutical Company Limited, Sinovac Biotech Ltd., Emergent BioSolutions Inc., Valneva SE, Novavax Inc., Dynavax Technologies Corporation, CureVac N.V., Inovio Pharmaceuticals Inc, and Mitsubishi Tanabe Pharma Corporation.

North America was the largest region in the vaccine technologies market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in vaccine technologies report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the vaccine technologies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The vaccine technologies market consists of revenues earned by entities by providing services such as vaccine research and development, formulation and testing, clinical trials management, regulatory support, manufacturing process optimization, and distribution logistics for vaccines. The market value includes the value of related goods sold by the service provider or included within the service offering. The vaccine technologies market also includes sales of mRNA vaccines, viral vector vaccines, protein subunit vaccines, and related raw materials and reagents used in vaccine development and production. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Vaccine Technologies Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on vaccine technologies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for vaccine technologies ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The vaccine technologies market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Recombinant Or Conjugate Or Subunit; Inactivated; Live Attenuated; Toxoid
2) By Route Of Administration: Parenteral; Oral; Nasal
3) By Disease Indication: Infectious Diseases; Non-Infectious Diseases
4) By Age Group: Pediatric; Adults
5) By Distribution Channel: Hospital And Retail Pharmacies; Government Suppliers; Other Distribution Channels
Subsegments:
1) By Recombinant Or Conjugate Or Subunit: Protein Subunit Vaccines; Virus-Like Particle (VLP) Vaccines; Glycoconjugate Vaccines; Recombinant Vector Vaccines
2) By Inactivated: Whole-Virus Inactivated Vaccines; Split-Virus Inactivated Vaccines; Purified Inactivated Vaccines
3) By Live Attenuated: Viral Live Attenuated Vaccines; Bacterial Live Attenuated Vaccines
4) By Toxoid: Diphtheria Toxoid Vaccines; Tetanus Toxoid Vaccines
Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Merck & Co. Inc; Sanofi S.A.; AstraZeneca plc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r36103

1. Executive Summary

2. Vaccine Technologies Market Characteristics

3. Vaccine Technologies Market Trends And Strategies

4. Vaccine Technologies Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Vaccine Technologies Growth Analysis And Strategic Analysis Framework

5.1. Global Vaccine Technologies PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Vaccine Technologies Market Growth Rate Analysis
5.4. Global Vaccine Technologies Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Vaccine Technologies Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Vaccine Technologies Total Addressable Market (TAM)

6. Vaccine Technologies Market Segmentation

6.1. Global Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Recombinant Or Conjugate Or Subunit
Inactivated
Live Attenuated
Toxoid
6.2. Global Vaccine Technologies Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Parenteral
Oral
Nasal
6.3. Global Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Infectious Diseases
Non-Infectious Diseases
6.4. Global Vaccine Technologies Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pediatric
Adults
6.5. Global Vaccine Technologies Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital And Retail Pharmacies
Government Suppliers
Other Distribution Channels
6.6. Global Vaccine Technologies Market, Sub-Segmentation Of Recombinant Or Conjugate Or Subunit, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Protein Subunit Vaccines
Virus-Like Particle (VLP) Vaccines
Glycoconjugate Vaccines
Recombinant Vector Vaccines
6.7. Global Vaccine Technologies Market, Sub-Segmentation Of Inactivated, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Whole-Virus Inactivated Vaccines
Split-Virus Inactivated Vaccines
Purified Inactivated Vaccines
6.8. Global Vaccine Technologies Market, Sub-Segmentation Of Live Attenuated, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Viral Live Attenuated Vaccines
Bacterial Live Attenuated Vaccines
6.9. Global Vaccine Technologies Market, Sub-Segmentation Of Toxoid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Diphtheria Toxoid Vaccines
Tetanus Toxoid Vaccines

7. Vaccine Technologies Market Regional And Country Analysis

7.1. Global Vaccine Technologies Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Vaccine Technologies Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Vaccine Technologies Market

8.1. Asia-Pacific Vaccine Technologies Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Vaccine Technologies Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Vaccine Technologies Market

9.1. China Vaccine Technologies Market Overview
9.2. China Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Vaccine Technologies Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Vaccine Technologies Market

10.1. India Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Vaccine Technologies Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Vaccine Technologies Market

11.1. Japan Vaccine Technologies Market Overview
11.2. Japan Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Vaccine Technologies Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Vaccine Technologies Market

12.1. Australia Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Vaccine Technologies Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Vaccine Technologies Market

13.1. Indonesia Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Vaccine Technologies Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Vaccine Technologies Market

14.1. South Korea Vaccine Technologies Market Overview
14.2. South Korea Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Vaccine Technologies Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Vaccine Technologies Market

15.1. Western Europe Vaccine Technologies Market Overview
15.2. Western Europe Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Vaccine Technologies Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Vaccine Technologies Market

16.1. UK Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Vaccine Technologies Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Vaccine Technologies Market

17.1. Germany Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Vaccine Technologies Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Vaccine Technologies Market

18.1. France Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Vaccine Technologies Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Vaccine Technologies Market

19.1. Italy Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Vaccine Technologies Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Vaccine Technologies Market

20.1. Spain Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Vaccine Technologies Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Vaccine Technologies Market

21.1. Eastern Europe Vaccine Technologies Market Overview
21.2. Eastern Europe Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Vaccine Technologies Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Vaccine Technologies Market

22.1. Russia Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Vaccine Technologies Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Vaccine Technologies Market

23.1. North America Vaccine Technologies Market Overview
23.2. North America Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Vaccine Technologies Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Vaccine Technologies Market

24.1. USA Vaccine Technologies Market Overview
24.2. USA Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Vaccine Technologies Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Vaccine Technologies Market

25.1. Canada Vaccine Technologies Market Overview
25.2. Canada Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Vaccine Technologies Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Vaccine Technologies Market

26.1. South America Vaccine Technologies Market Overview
26.2. South America Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Vaccine Technologies Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Vaccine Technologies Market

27.1. Brazil Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Vaccine Technologies Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Vaccine Technologies Market

28.1. Middle East Vaccine Technologies Market Overview
28.2. Middle East Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Vaccine Technologies Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Vaccine Technologies Market

29.1. Africa Vaccine Technologies Market Overview
29.2. Africa Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Vaccine Technologies Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Vaccine Technologies Market Competitive Landscape And Company Profiles

30.1. Vaccine Technologies Market Competitive Landscape
30.2. Vaccine Technologies Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck & Co. Inc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis

31. Vaccine Technologies Market Other Major And Innovative Companies

31.1. Novartis AG
31.2. GSK plc
31.3. Moderna Inc.
31.4. CSL Limited
31.5. Bharat Biotech International Limited
31.6. Bavarian Nordic A/S
31.7. Takeda Pharmaceutical Company Limited
31.8. Sinovac Biotech Ltd.
31.9. Emergent BioSolutions Inc.
31.10. Valneva SE
31.11. Novavax Inc.
31.12. Dynavax Technologies Corporation
31.13. CureVac N.V.
31.14. Inovio Pharmaceuticals Inc
31.15. Mitsubishi Tanabe Pharma Corporation

32. Global Vaccine Technologies Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Vaccine Technologies Market

34. Recent Developments In The Vaccine Technologies Market

35. Vaccine Technologies Market High Potential Countries, Segments and Strategies

35.1 Vaccine Technologies Market In 2029 - Countries Offering Most New Opportunities
35.2 Vaccine Technologies Market In 2029 - Segments Offering Most New Opportunities
35.3 Vaccine Technologies Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer